NCT01208922 - Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea | Biotech Hunter

Enrollment

835

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2016

Study Completion Date

May 31, 2016

Conditions

Traveler's Diarrhea

Interventions

DRUG

Rifamycin SV-MMX®

2 Rifamycin SV-MMX® 200 mg tablets and 1 placebo to ciprofloxacin capsule, b.i.d.

DRUG

Ciprofloxacin

1 ciprofloxacin 500 mg capsule and 2 placebos to Rifamycin SV-MMX® 200 mg tablets, b.i.d.

Trial Locations (19)

Site 401, Quito

Site 200, Quetzaltenango

Site 101, Mapusa

Site 124, Ajmer

Site 118, Bardez

Site 120, Calangute

Site 104, Hyderabad

Site 114, Kolkata

Site 116, Lucknow

Site 107, Madgaon

Site 110, Madgaon

Site 123, New Delhi

Site 122, Panjim

Site 102, Puducherry

Site 115, Pushkar

Site 119, Salcette

Site 111, Tiswadi

Site 109, Varanasi

Site 103, Vijayawada